The 2024 RSNA Annual Meeting is one of the largest medical imaging conferences in the world that provides professionals across the radiology specialty with opportunities to connect and learn about the latest innovations.
BGL Managing Director Christoph Brandenberger will be attending this year’s conference and available to discuss the life sciences market, including upcoming opportunities in the medical device M&A.
BGL’s Diagnostics, Research Tools & Medical Devices investment banking team has decades of experience advising companies across the diagnostics and device landscape. With this in-depth knowledge and background, we have provided M&A and capital markets strategy for a wide range of companies in this sector.